Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal ...

To save money on your Gvoke prescription, explore these Optum Perks coupons for Gvoke HypoPen and other forms of the drug. Gvoke for subcutaneous injection is only available as a brand-name drug.

and debut the auto-injector version (Gvoke HypoPen) in early 2020. The FDA’s decision on Gvoke was originally due in June, but was delayed by three months as a result of a major amendment to ...

Key products include Gvoke for severe hypoglycemia, Keveyis for Primary Periodic Paralysis, and Recorlev for Cushing's Syndrome, with Recorlev showing strong growth. The company has a promising ...

The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the ...

InvestingPro analysis reveals 8 additional key insights about the company’s potential. Gvoke VialDx™ is designed to temporarily inhibit gastrointestinal movement during diagnostic procedures ...